Solid Biosciences Inc. SLDB
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2018-01-26
Solid Biosciences Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| CITADEL ADVISORS LLC | 2,648,200 | $19.1M | 3.03% |
| Point72 Asset Management, L.P. | 2,050,843 | $14.8M | 2.34% |
| BlackRock Finance, Inc. | 1,483,262 | $8.4M | 1.7% |
| MILLENNIUM MANAGEMENT LLC | 363,675 | $2.6M | 0.42% |
| AQR CAPITAL MANAGEMENT LLC | 151,541 | $1.1M | 0.17% |
| D. E. Shaw & Co., Inc. | 128,348 | $924,106 | 0.15% |
| RENAISSANCE TECHNOLOGIES LLC | 124,272 | $894,758 | 0.14% |
| TWO SIGMA INVESTMENTS, LP | 92,207 | $663,890 | 0.11% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.